+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diagnostic Enzymes Market Size, Share & Trends Analysis Report By Type (Taq Polymerase, MMLV RT, HIV RT), Application (Diabetes, Oncology, Cardiology), Product Type, By Region, And Segment Forecasts, 2022 - 2030

  • PDF Icon

    Report

  • 129 Pages
  • November 2022
  • Region: Global
  • Grand View Research
  • ID: 5702129
The global diagnostic enzymes market size is expected to reach USD 6.26 billion by 2030, registering a CAGR of 3.97% during the forecast period.Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Diagnostic Enzymes Market Report Highlights

  • In 2021, the glucose oxidase/glucose dehydrogenase enzyme segment held a dominant share in the market owing to the presence of an abundance of enzymes in living organisms
  • The oncology segment is projected to grow at the fastest rate during the forecast period owing to the increasing prevalence of cancer among the population
  • The clinical segment is the highest revenue-generating segment in 2021 owing to the increased focus on R&D
  • The diagnostic enzyme market is witnessing change owing to the presence of key market players focusing on product launches and geographic expansion to maintain their position in the market
  • Asia Pacific is expected to witness the fastest growth during the forecast period owing to the improved manufacturing facilities and the presence of the target population


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Diagnostic Enzymes Market Variables, Trends, & Scope
3.1 Diagnostic Enzymes Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook - In Vitro Diagnostics (IVD) Market
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.4 Market Driver Analysis
3.4.1 Rise in the demand for enzymes in diagnostics
3.4.2 Wide applications of enzymes in pathology
3.4.3 Advancements in diagnostic testing of viral infections
3.4.4 Increase in the demand for Point-of-Care testing
3.5 Market Restraint Analysis
3.5.1 High cost of enzyme-based diagnostic tests
3.5.2 Regulatory & reimbursement hurdles for enzyme diagnostics
3.6 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.7 Porter’s Five Forces Analysis
Chapter 4 Diagnostic Enzymes Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Diagnostic Enzymes Market: Type Movement Analysis
4.1.1 Taq Polymerase
4.1.1.1 Taq Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.2 MMLV RT
4.1.2.1 MMLV RT Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.3 HIV RT
4.1.3.1 HIV RT Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.4 Hot Start Taq Pol
4.1.4.1 Hot Start Taq Pol Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.5 UNG
4.1.5.1 UNG Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.6 Rnase Inhibitors
4.1.6.1 Rnase Inhibitors Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.7 Bst Polymerase (LAMP Enzyme)
4.1.7.1 Bst Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.8 PCR Master Mix
4.1.8.1 PCR Master Mix Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.9 Lyophilized Polymerase
4.1.9.1 Lyophilized Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.10 T7 RNA Polymerase
4.1.10.1 T7 RNA Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.11 Cas9 Enzyme
4.1.11.1 Cas9 Enzyme Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.12 Acid Phosphatase
4.1.12.1 Acid Phosphatase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.13 Alanine Aminotransferase
4.1.13.1 Alanine Aminotransferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.14 Alkaline Phosphatase
4.1.14.1 Alkaline Phosphatase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.15 Amylase
4.1.15.1 Amylase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.16 Angiotensin Converting Enzyme
4.1.16.1 Angiotensin Converting Enzyme Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.17 Aspartate Aminotransferase
4.1.17.1 Aspartate Aminotransferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.18 Cholinesterase
4.1.18.1 Cholinesterase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.19 Creatinine Kinase
4.1.19.1 Creatinine Kinase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.20 Gamma Glutamyl Transferase
4.1.20.1 Gamma Glutamyl Transferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.21 Lactate Dehydrogenase
4.1.21.1 Lactate Dehydrogenase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.22 Renin
4.1.22.1 Renin Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.23 Glucose Oxidase/Glucose Dehydrogenase
4.1.23.1 Glucose Oxidase/Glucose Dehydrogenase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.24 Urease
4.1.24.1 Urease Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.25 Lactate Oxidase
4.1.25.1 Lactate Oxidase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.26 Horseradish Peroxide
4.1.26.1 Horseradish Peroxide Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.27 Glutamate Oxidase
4.1.27.1 Glutamate Oxidase Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.28 Others
4.1.28.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Diagnostic Enzymes Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
5.1 Diagnostic Enzymes Market: Application Movement Analysis
5.1.1 Diabetes
5.1.1.1 Diabetes Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.2 Oncology
5.1.2.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.3 Cardiology
5.1.3.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.4 Infectious Diseases
5.1.4.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.5 Nephrology
5.1.5.1 Nephrology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.6 Autoimmune Diseases
5.1.6.1 Autoimmune Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.7 Others
5.1.7.1 Others Market Estimates And Forecast, 2017-2030, USD Million
Chapter 6 Diagnostic Enzymes Market - Segment Analysis, By Product Type, 2018 - 2030 (USD Million)
6.1 Diagnostic Enzymes Market: Product Type Movement Analysis
6.1.1 Molecular Enzymes
6.1.1.1 Molecular Enzymes Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.1.2 Clinical Enzymes
6.1.2.1 Clinical Enzymes Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 Diagnostic Enzymes Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)
7.1 Diagnostic Enzymes Market: Regional Movement Analysis
7.2 North America
7.2.1 North America Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.3.2 UK
7.3.2.1 UK Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 China Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.5 Rest of World
7.5.1 Rest of World Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
7.5.3 South Africa
7.5.3.1 South Africa Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
Chapter 8 Diagnostic Enzymes Market: Competitive Analysis
8.1 Recent developments and impact analysis, by key market participants
8.1.1 Ansoff Matrix
8.1.2 Major Deals And Strategic Alliances Analysis
8.1.2.1 Market Expansion
8.1.2.2 Product Launch
8.1.2.3 Acquisition
8.1.2.4 Partnerships and Collaborations
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List Of Key Distributors And Channel Partners
8.3.2 Key Customers
8.3.3 Key Company Market Share Analysis, 2021
8.4 Public Companies
8.4.1 Company Market Position Analysis
8.4.2 Heat Map Analysis
8.4.3 Regional Network Map
8.4.4 Competitive Dashboard Analysis
8.4.4.1 Market Differentiators
8.5 Private Companies
8.5.1 List Of Key Emerging Companies
8.5.2 Heat Map Analysis
8.5.3 Regional Network Map
Chapter 9 Company Profiles
9.1 Takara Bio, Inc.
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Promega Corporation
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Enzo Life Sciences, Inc.
9.3.1 Company Overview
9.3.2 Product Benchmarking
9.4 Merck KGaA
9.4.1 Company Overview
9.4.1.1 Sigma-Aldrich Co. Llc
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Creative Enzymes
9.6.1 Company Overview
9.6.2 Product Benchmarking
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Solis BioDyne
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.9 Ampliqon A/S
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global diagnostic enzymes market, by region, 2018 - 2030 (USD Million)
TABLE 5 Global diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 6 Global diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 7 Global diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 8 North America diagnostic enzymes market, by country, 2018 - 2030 (USD Million)
TABLE 9 North America diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 10 North America diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 11 North America diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 12 U.S. diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 13 U.S. diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 14 U.S. diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 15 Canada diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 16 Canada diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 17 Canada diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 18 Europe diagnostic enzymes market, 2018 - 2030 (USD Million)
TABLE 19 Europe diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 20 Europe diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 21 Europe diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 22 UK diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 23 UK diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 24 UK diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 25 Germany diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 26 Germany diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 27 Germany diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 28 France diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 29 France diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 30 France diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 31 Asia Pacific diagnostic enzymes market, 2018 - 2030 (USD Million)
TABLE 32 Asia Pacific diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 33 Asia Pacific diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 34 Asia Pacific diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 35 Japan diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 36 Japan diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 37 Japan diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 38 China diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 39 China diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 40 China diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 41 India market, by type, 2018 - 2030 (USD Million)
TABLE 42 India diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 43 India diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 44 Rest of Worlddiagnostic enzymes market, 2018 - 2030 (USD Million)
TABLE 45 Rest of Worlddiagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 46 Rest of Worlddiagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 47 Rest of Worlddiagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 48 Brazil diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 49 Brazil diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 50 Brazil diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
TABLE 51 South Africa diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
TABLE 52 South Africa diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
TABLE 53 South Africa diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Diagnostic enzymes market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Diagnostic enzymes market snapshot
FIG. 10 Penetration and growth prospect mapping for application, 2021 (USD Million)
FIG. 11 Market Dynamics
FIG. 12 Diagnostic enzymes market driver impact
FIG. 13 Enzymes in the diagnosis of diseases
FIG. 14 Common applications of enzymes in pathology
FIG. 15 Diagnostic enzymes market restraint impact
FIG. 16 Porter’s five forces analysis
FIG. 17 Diagnostic enzymes market: Type outlook and key takeaways
FIG. 18 Common diagnostic enzymes
FIG. 19 Taq polymerase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 20 MMLV-RT market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 21 HIV RT market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 22 Evaluation Index of Antibody Modified Hot Start Taq DNA Polymerase
FIG. 23 Hot start Taq pol market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 24 UNG market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 25 RNase inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 26 Bst polymerase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 27 PCR master mix market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 28 Lyophilized polymerase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 29 T7 RNA polymerase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 30 Cas9 enzyme market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 31 Acid phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 32 Alanine aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 33 Alkaline phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 34 Amylase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 35 Angiotensin-converting enzyme market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 36 Aspartate aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 37 Cholinesterase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 38 Creatinine kinase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 39 Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 40 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 41 Renin market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 42 Glucose oxidase/Glucose dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 43 Urease market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 44 Lactate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 45 Horseradish peroxide market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 46 Glutamate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 47 Others market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 48 Diagnostic enzymes market : Application outlook and key takeaways
FIG. 49 Diagnostic enzymes market: Application movement analysis
FIG. 50 Global diabetes prevalence data and forecast (numbers in million)
FIG. 51 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 52 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 53 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 54 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 55 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 56 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 57 Others market estimates and forecast, 2017-2030, USD Million
FIG. 58 Diagnostic enzymes market : Application outlook and key takeaways
FIG. 59 Diagnostic enzymes market: Product type movement analysis
FIG. 60 Molecular enzymes market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 61 Clinical enzymes market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 62 Diagnostic Enzymes Market: Regional outlook and key takeaways
FIG. 63 Diagnostic enzyme market: Regional movement analysis
FIG. 64 North America
FIG. 65 North America. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 66 U.S.
FIG. 67 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 68 Canada
FIG. 69 Canada market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 70 Europe
FIG. 71 Europe market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 72 UK
FIG. 73 UK market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 74 Germany
FIG. 75 Germany market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 76 France
FIG. 77 France market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 78 Asia Pacific
FIG. 79 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 80 Japan
FIG. 81 Japan market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 82 China
FIG. 83 China. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 84 India
FIG. 85 India. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 86 Rest of World
FIG. 87 Rest of world market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 88 Brazil
FIG. 89 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 90 South Africa
FIG. 91 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 92 Ansoff Matrix
FIG. 93 Strategy mapping
FIG. 94 Company market share analysis, 2021
FIG. 95 Company market position analysis
FIG. 96 Company market position analysis
FIG. 97 Heat Map Analysis
FIG. 98 Market differentiators
FIG. 99 Heat Map Analysis
FIG. 100 Regional Network Map

Companies Mentioned

  • Takara Bio, Inc.
  • Promega Corporation
  • Enzo Life Sciences, Inc.
  • Merck Kgaa
  • Sigma-Aldrich Co. LLC
  • Thermo Fisher Scientific, Inc.
  • Creative Enzymes
  • F. Hoffmann-La Roche Ltd.
  • Solis Biodyne
  • Ampliqon A/S

Methodology

Loading
LOADING...

Table Information